| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8721886 | Digestive and Liver Disease | 2018 | 24 Pages |
Abstract
Sorafenib and fluvastatin synergistically alleviated diethylnitrosamine-induced hepatic fibrosis in rats. Sorafenib plus fluvastatin may be a potential combination treatment for hepatic fibrotic diseases.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Yang Cheng, Hang Zheng, Biao Wang, WanFu Xu, Jiajia Xu, Yun Zhu,